These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 48674)

  • 1. Triglyceride-production rates in patients with type-4 hypertriglyceridaemia.
    Kaye JP; Galton DJ
    Lancet; 1975 May; 1(7914):1005-7. PubMed ID: 48674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia.
    Krauss RM; Levy RI; Fredrickson DS
    J Clin Invest; 1974 Nov; 54(5):1107-24. PubMed ID: 4370795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridaemia associated with an abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-III-2.
    Stocks J; Holdsworth G; Galton D
    Lancet; 1979 Sep; 2(8144):667-71. PubMed ID: 90760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of serum triglyceride levels by polyunsaturated fat. Studies on the mode of action and on very low density lipoprotein composition.
    Chait A; Onitiri A; Nicoll A; Rabaya E; Davies J; Lewis B
    Atherosclerosis; 1974; 20(2):347-64. PubMed ID: 4370323
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD; Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The triglyceride content of adipocytes and plasma of patients with diabetes mellitus.
    Reckless JP; Clifton-Bligh P; Galton DJ
    Horm Metab Res; 1975 Sep; 7(5):407-10. PubMed ID: 1183920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
    Kashyap ML; Srivastava LS; Chen CY; Perisutti CG; Campbell M; Lutmer RF; Glueck CJ
    J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splanchnic secretion rates of plasma triglycerides and total and splanchnic turnover of plasma free fatty acids in men with normo- and hypertriglyceridaemia.
    Boberg J; Carlson LA; Freyschuss U; Lassers BW; Wahlqvist ML
    Eur J Clin Invest; 1972 Nov; 2(6):454-66. PubMed ID: 4655971
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental hypertriglyceridaemia and plasma PHLA in man.
    Elkeles RS; Hambley J; Chalmers RA
    Horm Metab Res; 1978 Sep; 10(5):447. PubMed ID: 711141
    [No Abstract]   [Full Text] [Related]  

  • 13. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
    Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
    Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of triglyceride in hyperlipidemia.
    Noma A; Orimo H
    Jpn Circ J; 1975 Mar; 39(3):334-8. PubMed ID: 1117586
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome.
    Taskinen MR; Nikkilä EA; Pelkonen R; Sane T
    J Clin Endocrinol Metab; 1983 Sep; 57(3):619-26. PubMed ID: 6348067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofibrate increases lipoprotein-lipase activity in adipose tissue of hypertriglyceridaemic patients.
    Taylor KG; Holdsworth G; Galton DJ
    Lancet; 1977 Nov; 2(8048):1106-7. PubMed ID: 73012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a defect in fatty acid uptake by adipose tissue of patients with hypertriglyceridaemia.
    Carlson LA; Walldius G; Olsson AG
    J Clin Pathol Suppl (Assoc Clin Pathol); 1973; 5():48-52. PubMed ID: 4270164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.